Evidence map›Paper›PMID 38755405›Full record

ArticleInflammation2025

Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies.

Zhou Pan, Mengdi Li, Panpan Zhang, Tianqi Li, Rui Liu, Jia Liu, Shengyun Liu, Yusheng Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. CD73RMD open · 2025
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhou Pan *Department of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mengdi Li *Department of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Panpan ZhangDepartment of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Tianqi LiDepartment of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Rui LiuDepartment of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jia LiuDepartment of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shengyun LiuDepartment of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China. fccliusy2@zzu.edu.cn.
Yusheng ZhangDepartment of Rheumatology and Clinical Immunology, The first affiliated Hospital of Zhengzhou University, Zhengzhou, China. zhendezy@163.com.

Funding

Joint project of Medical Science and Technology Key Program of Henan Province LHGJ20230175National Natural Science Foundation of China 82302051National Natural Science Foundation of China 82371819National Natural Science Foundation of China,China 82101889
6 · The paper itself

Abstract

Idiopathic inflammatory myopathies (IIM) are a group of myopathies that present with muscle weakness and multiple extra-muscular manifestations, in which lymphocytes play central roles in myositis pathogenesis. This study aimed to explore the clinical characteristics of lymphocyte subsets, especially B cell subsets, in patients with IIM. Our study included 176 patients with active IIM and 210 gender/age-matched healthy controls (HCs). Compared to HCs, patients have reduced counts of T cells, B cells, and natural killer cells. In addition, B cell subsets from 153 patients with IIM and 92 HCs were characterized. Patients had a lower percentage of memory B cells and translational memory B cells, while those patients were with an elevated percentage of CD19+ B cells, plasmablast and naïve B cells compared with HCs. Moreover, to further explore the heterogeneity of B cells in IIM, patients were categorized into three clusters based on clustering analysis. Cluster 1 was dominated by CD19+ B cells, Bregs and naïve B cells, cluster 3 was dominated by memory B cells and plasmablast, and cluster 2 had the highest proportion of translational memory B cells. Notably, patients in cluster 1 presented with higher CK levels, indicating muscle damage, whereas patients in cluster 3 showed a higher incidence of chest tightness. Our study indicated that lymphopenia is a common manifestation in patients with IIM. B cell subsets are abnormally expressed and showed high heterogeneity in patients with IIM. The patients with IIM were divided into three different clusters with different percentages of chest tightness and distinct CK levels.

Indexed as

AutoantibodiesB-Lymphocyte SubsetsMyositisAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedAutoantibodiesB cell subsetscluster analysis.idiopathic inflammatory myositislymphocytes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.